Dementia Treatment
-
{
- All
- News
- Videos
-
More Weight Loss While On Ozempic Means Lower Risk Of Obesity-Related Diseases, Says New Study
The new analysis suggests that greater weight loss achieved while taking Ozempic and similar GLP-1 medications may lead to a larger reduction in obesity-related disease risk.
-
Women With Parkinson's More Likely To Experience Falls, Report Higher Rates Of Pain Than Men: Study
Men, on the other hand, were more likely to report memory changes and showed higher rates of cognitive impairment, according to findings published in the The Lancet Regional Health Western Pacific journal.
-
What I Tell Families When They Ask: Should We Put My Parent On The New Drug, Lormalzi?
Lormalzi is not a cure. I say this not to take away hope, but because understanding this is what allows families to make decisions rooted in reality rather than desperation.
-
Who Should Take Lormalzi? Alzheimer's Expert Explains Benefits And Risks
Neurologists say Lormalzi (donanemab), India's newly launched Alzheimer's therapy, may help slow cognitive decline in carefully selected patients with early disease. Experts explain who may benefit, who should avoid it, and the risks involved.
-
Eli Lilly Launches Alzheimer's Drug Lormalzi Priced At Rs 91,688 Per Vial In India
Eli Lilly has launched Lormalzi (donanemab) in India for early Alzheimer's disease at Rs91,688 per vial. The once-monthly therapy targets amyloid plaques and may help slow cognitive decline in eligible patients with mild symptoms.
-
Scientists Reverse Brain Ageing With Nasal Spray In Landmark Study
Scientists at Texas A&M University have developed a nasal spray that reduces chronic brain inflammation, restores memory and reverses signs of brain ageing in animal models, raising hopes for future treatments for dementia and other neurodegenerative conditions.
-
Alzheimer's Amyloid-Targeting Drugs Show No Clear Clinical Benefit: Review
Drugs designed to treat Alzheimer's disease by targeting amyloid proteins was seen in high amounts in patients' brains, but it has no clinically meaningful positive effects, according to a new review of previously published studies has found.
-
Memory Problems Are Not Always Age-Related, Say Neurologists: This Is When Cognitive Changes Need Attention
Understanding the difference between age-related memory lapses and signs of cognitive decline is essential for early diagnosis and effective management.
-
Can Low Birthweight Predict Stroke Risk? Doctor Breaks Down New Swedish Study
Low birth weight is linked to a higher risk of stroke in early adulthood, affecting both ischemic and hemorrhagic stroke types.
-
Overlooked And More Aggressive Parkinson's Variant Hits Indians Harder: Study Finds
A NIMHANS study warns that atypical Parkinsonism, an often-misdiagnosed variant, may progress faster and harm Indian patients more severely.
-
1 In 7 Stroke Patients In India Are Under 45: Alarming National Registry Data
A new National Stroke Registry analysis reveals nearly 14 % of stroke patients in India are under 45, a demographic once considered low risk.
-
Early Alzheimer's Detection Is Changing How Indian Families Plan Daily Life; Doctor Explains Shift
Forgetting routes and repeating questions may not be normal ageing. Early Alzheimer's detection is helping Indian families prepare emotionally, medically and financially, says neurologist Dr Renjen.
-
Targeting Brain Network May Make Parkinson's Treatment More Effective: Study
A study has suggested that treatments for Parkinson's disease could potentially be doubly efficacious by targeting a brain network linking cognition and action, rather than brain regions responsible for movements.
-
Hearing Loss An Early Warning Sign For Alzheimer's, Study Warns: Don't Ignore These Other Red Flags
A growing body of research now points to hearing loss as a compelling early indicator of Alzheimer's disease.
-
Doctor Shares Tips To Slow Down The Progression Of Alzheimer's Disease
Alzheimer's disease is the most common cause of dementia. While there's no cure for dementia, medication and treatments like cognitive behavioural therapy might help manage symptoms.
-
More Weight Loss While On Ozempic Means Lower Risk Of Obesity-Related Diseases, Says New Study
The new analysis suggests that greater weight loss achieved while taking Ozempic and similar GLP-1 medications may lead to a larger reduction in obesity-related disease risk.
-
Women With Parkinson's More Likely To Experience Falls, Report Higher Rates Of Pain Than Men: Study
Men, on the other hand, were more likely to report memory changes and showed higher rates of cognitive impairment, according to findings published in the The Lancet Regional Health Western Pacific journal.
-
What I Tell Families When They Ask: Should We Put My Parent On The New Drug, Lormalzi?
Lormalzi is not a cure. I say this not to take away hope, but because understanding this is what allows families to make decisions rooted in reality rather than desperation.
-
Who Should Take Lormalzi? Alzheimer's Expert Explains Benefits And Risks
Neurologists say Lormalzi (donanemab), India's newly launched Alzheimer's therapy, may help slow cognitive decline in carefully selected patients with early disease. Experts explain who may benefit, who should avoid it, and the risks involved.
-
Eli Lilly Launches Alzheimer's Drug Lormalzi Priced At Rs 91,688 Per Vial In India
Eli Lilly has launched Lormalzi (donanemab) in India for early Alzheimer's disease at Rs91,688 per vial. The once-monthly therapy targets amyloid plaques and may help slow cognitive decline in eligible patients with mild symptoms.
-
Scientists Reverse Brain Ageing With Nasal Spray In Landmark Study
Scientists at Texas A&M University have developed a nasal spray that reduces chronic brain inflammation, restores memory and reverses signs of brain ageing in animal models, raising hopes for future treatments for dementia and other neurodegenerative conditions.
-
Alzheimer's Amyloid-Targeting Drugs Show No Clear Clinical Benefit: Review
Drugs designed to treat Alzheimer's disease by targeting amyloid proteins was seen in high amounts in patients' brains, but it has no clinically meaningful positive effects, according to a new review of previously published studies has found.
-
Memory Problems Are Not Always Age-Related, Say Neurologists: This Is When Cognitive Changes Need Attention
Understanding the difference between age-related memory lapses and signs of cognitive decline is essential for early diagnosis and effective management.
-
Can Low Birthweight Predict Stroke Risk? Doctor Breaks Down New Swedish Study
Low birth weight is linked to a higher risk of stroke in early adulthood, affecting both ischemic and hemorrhagic stroke types.
-
Overlooked And More Aggressive Parkinson's Variant Hits Indians Harder: Study Finds
A NIMHANS study warns that atypical Parkinsonism, an often-misdiagnosed variant, may progress faster and harm Indian patients more severely.
-
1 In 7 Stroke Patients In India Are Under 45: Alarming National Registry Data
A new National Stroke Registry analysis reveals nearly 14 % of stroke patients in India are under 45, a demographic once considered low risk.
-
Early Alzheimer's Detection Is Changing How Indian Families Plan Daily Life; Doctor Explains Shift
Forgetting routes and repeating questions may not be normal ageing. Early Alzheimer's detection is helping Indian families prepare emotionally, medically and financially, says neurologist Dr Renjen.
-
Targeting Brain Network May Make Parkinson's Treatment More Effective: Study
A study has suggested that treatments for Parkinson's disease could potentially be doubly efficacious by targeting a brain network linking cognition and action, rather than brain regions responsible for movements.
-
Hearing Loss An Early Warning Sign For Alzheimer's, Study Warns: Don't Ignore These Other Red Flags
A growing body of research now points to hearing loss as a compelling early indicator of Alzheimer's disease.
-
Doctor Shares Tips To Slow Down The Progression Of Alzheimer's Disease
Alzheimer's disease is the most common cause of dementia. While there's no cure for dementia, medication and treatments like cognitive behavioural therapy might help manage symptoms.
